Clinical Trial: Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease

U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT04847011) titled 'Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease' on April 14.

Brief Summary: The ExpoBiome project will analyze the impact of fasting on patients with Parkinsons's Disease (PD) or rheumatoid arthritis (RA) on a clinical level as well as the effect of fasting on their immune system and gut microbiota. ExpoBiome will combine metagenomics and other "omics" [meta-transcriptomics, meta-proteomics and (meta-)metabolomics], bioinformatic analyses and biostatistics under a systems biology framework to gain new mechanistic insights into microbiome-immune system interactions i...